Ultromics Blog Diagnosing Cardiac Amyloidosis: Challenges and Current Gaps in Detection

Despite the early detection of Cardiac Amyloidosis being critical for extending survival and improving quality of life (QoL), delayed and misdiagnoses are common.1 In one survey of 500 patients, for example, the average time from symptom onset to diagnosis was two years, and 31.8% reported seeing at least five healthcare professionals during this period.2 There is no denying that the condition, which often mimics other heart diseases, is challenging to detect. But with more accessible, standardized screening and diagnostic approaches, the healthcare community could ensure more people access the right interventions at the right time.